Esperion Therapeutics, Inc. (ESPR)
NASDAQ: ESPR · Real-Time Price · USD
2.480
+0.070 (2.90%)
Nov 21, 2024, 1:14 PM EST - Market open

Esperion Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Nov '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Market Capitalization
4893404593067251,630
Upgrade
Market Cap Growth
208.78%-25.93%49.97%-57.77%-55.52%32.13%
Upgrade
Enterprise Value
5997578157266871,515
Upgrade
Last Close Price
2.412.996.235.0026.0059.63
Upgrade
PS Ratio
1.362.926.083.903.1910.98
Upgrade
PB Ratio
-0.87-0.75-1.42-1.55-7.5481.68
Upgrade
P/TBV Ratio
-----81.91
Upgrade
EV/Sales Ratio
2.036.5010.799.263.0210.21
Upgrade
Debt / Equity Ratio
-0.73-1.19-1.56-2.63-3.776.72
Upgrade
Asset Turnover
1.100.510.240.210.800.83
Upgrade
Inventory Turnover
1.632.574.194.76--
Upgrade
Quick Ratio
1.280.842.173.853.373.04
Upgrade
Current Ratio
1.851.292.674.483.683.20
Upgrade
Return on Equity (ROE)
------196.16%
Upgrade
Return on Assets (ROA)
3.84%-42.86%-35.64%-36.31%-26.73%-32.52%
Upgrade
Return on Capital (ROIC)
101.42%-72.90%-44.78%-45.52%-36.14%-49.91%
Upgrade
Earnings Yield
-18.27%-61.54%-50.90%-87.91%-19.81%-5.96%
Upgrade
FCF Yield
-5.49%-39.85%-38.08%-86.18%-11.87%-4.38%
Upgrade
Buyback Yield / Dilution
-78.21%-55.26%-129.76%-5.20%-1.42%-1.26%
Upgrade
Total Shareholder Return
-78.21%-55.26%-129.76%-5.20%-1.42%-1.26%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.